Ganga Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2024 |
|---|---|
| Revenue | TBA |
| Operating Expense | TBA |
| Net Profit | TBA |
| Net Profit Margin | TBA |
| Earning Per Share | TBA |
| EBIDTA | TBA |
| Effective Tax Rate | TBA |
| Particulars | Jun 2024 |
|---|---|
| Revenue | TBA |
| Operating Expense | TBA |
| Net Profit | TBA |
| Net Profit Margin | TBA |
| Earning Per Share | TBA |
| EBIDTA | TBA |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 2.64 | 2.74 | 2.59 |
| Operating Expenses Annual | 2.75 | 2.68 | 2.58 |
| Operating Profit Annual | 0.32 | 0.30 | 0.30 |
| Interest Annual | 0.18 | 0.18 | 0.19 |
| Depreciation | 0.05 | 0.05 | 0.06 |
| Net Profit Annual | 0.08 | 0.05 | 0.04 |
| Tax Annual | 0.02 | 0.02 | 0.01 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 2.64 |
| Operating Expenses Annual | 2.75 |
| Operating Profit Annual | 0.32 |
| Interest Annual | 0.18 |
| Depreciation | 0.05 |
| Net Profit Annual | 0.08 |
| Tax Annual | 0.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.03 | 0.03 | 0.02 |
| Cash Flow from Operations | -0.58 | -1.26 | -0.04 |
| Cash Flow from Investing | 1.18 | 0.13 | 0.49 |
| Cash Flow from Financing | -0.33 | 1.14 | -0.44 |
| Cash Flow at the End | 0.30 | 0.03 | 0.03 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.03 |
| Cash Flow from Operations | -0.58 |
| Cash Flow from Investing | 1.18 |
| Cash Flow from Financing | -0.33 |
| Cash Flow at the End | 0.30 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 12.12 | 10.58 | 11.58 |
| PBIT Margin (%) | 10.23 | 8.76 | 9.27 |
| PBT Margin (%) | -48.86 | -41.97 | -39.38 |
| Net PROFIT Margin (%) | 3.03 | 1.82 | 1.54 |
| Return On Networth / Equity (%) | 1.13 | 0.80 | 0.74 |
| Return On Networth /Employed (%) | 3.30 | 3.18 | 3.28 |
| Return On Assets (%) | 0.94 | 0.64 | 0.54 |
| Total Debt / Equity (X) | 0.20 | 0.25 | 0.35 |
| Asset Turnover Ratio (%) | 0.31 | 0.35 | 0.35 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 12.12 |
| PBIT Margin (%) | 10.23 |
| PBT Margin (%) | -48.86 |
| Net PROFIT Margin (%) | 3.03 |
| Return On Networth / Equity (%) | 1.13 |
| Return On Networth /Employed (%) | 3.30 |
| Return On Assets (%) | 0.94 |
| Total Debt / Equity (X) | 0.20 |
| Asset Turnover Ratio (%) | 0.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.66 | 0.61 | 0.64 |
| Total Current Assets Annual | 6.87 | 5.75 | 5.15 |
| Non Current Assets Annual | 2.11 | 2.90 | 2.84 |
| Total Shareholders Funds Annual | 7.13 | 7.05 | 5.45 |
| Total Assets Annual | 8.97 | 8.65 | 7.98 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.66 |
| Total Current Assets Annual | 6.87 |
| Non Current Assets Annual | 2.11 |
| Total Shareholders Funds Annual | 7.13 |
| Total Assets Annual | 8.97 |
No Data Availabe
